A panel talks about what Congress, pharmaceutical companies, and the health care infrastructure are doing to make sure there are enough antibiotics and other tools available to cope with the anthrax attacks.

Guests

  • Dr. Shelley Hearne executive director of the Trust for America's Health and visiting professor at Johns Hopkins University's Bloomberg School of Public Health
  • Dr. Steve Bende of the Generic Pharmaceutical Association
  • Dr. Anthony Fauci Director of the National Institute of Allergy and Infectious Diseases/NIH

Related Links

Topics + Tags

Comments

comments powered by Disqus
Most Recent Shows

What Brexit Means For The U.S.

Tuesday, Jun 28 2016With a now-likely U.K. exit from the EU, America’s relationship with a key intelligence and global trade ally will change. Please join us to discuss what the British vote means for the U.S. economy, the 2016 presidential campaign and global security.

The Fallout From The Brexit Vote

Monday, Jun 27 2016The world reacts to Brexit: European Union leaders plan for Great Britain's departure and investors brace for more uncertainty, as the U.S. considers economic and strategic implications.